Company Profile

Formerly doing business as Dorlin Pharmaceuticals and before that CheckTec Corporation, Amulet Pharmaceuticals Inc is an infectious disease drug discovery company. The company's goals are to exploit newly discovered therapeutic targets for identification of novel compounds that will be suitable antibiotic agents. Amulet has a novel drug delivery platform technology that can be adapted to a wide variety of medical applications. The platform is based on predictable and controllable release of nitric oxide and unique methods of nitric oxide delivery. Amulet developed its own novel composition–of-matter intellectual property (NORTECH™) and began segmenting it's NORTECH™ technology into dozens of well defined markets. This effort began with a sale of a NORTECH™ application to Noxilizer Inc for the medical sterilization market.